High Drinking in the Dark (HDID) Mice Are Sensitive to the Effects of Some Clinically Relevant Drugs to Reduce Binge-like Drinking

BACKGROUND: There is a serious public health need for better understanding of alcohol use disorder disease mechanisms and for improved treatments. At this writing, only three drugs are approved by the Food and Drug Administration as medications to treat alcohol use disorders – disulfiram, naltrexone...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmacol Biochem Behav
Main Authors: Crabbe, John C, Ozburn, Angela R, Metten, Pamela, Barkley-Levenson, Amanda, Schlumbohm, Jason P., Spence, Stephanie E., Hack, Wyatt R, Huang, Lawrence C.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5603423/
https://ncbi.nlm.nih.gov/pubmed/28827047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2017.08.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares